NeoGenomics holder reports 8.37% beneficial stake
First Light Asset Management, LLC and Mathew P. Arens report their beneficial ownership of NeoGenomics, Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
First Light Asset Management, LLC and Mathew P. Arens report their beneficial ownership of NeoGenomics, Inc. common stock. First Light Asset Management may be deemed to beneficially own 10,260,186 shares, representing 7.99% of the common stock. These shares are held in separately managed accounts and private funds for which the Manager serves as investment adviser.
Mathew P. Arens may be deemed to beneficially own 10,759,586 shares, or 8.37% of the common stock, including 235,000 shares held directly with sole control and 264,400 shares in a joint account with shared control. Voting and dispositive powers are primarily shared through the Manager. The reporting persons state that these disclosures are made solely for purposes of Section 13(d) of the Exchange Act and are not an admission of beneficial ownership for other purposes.
Key Figures
Key Terms
beneficial owner financial
sole dispositive power financial
Schedule 13(d) regulatory
separately managed accounts financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of NeoGenomics (NEO) does Mathew P. Arens report owning?
How much of NeoGenomics (NEO) does First Light Asset Management beneficially own as a percentage?
What type of control does Mathew P. Arens report over his NeoGenomics (NEO) holdings?
Where are the reporting persons for the NeoGenomics (NEO) Schedule 13G/A based?
AI-generated analysis. How Rhea-AI works. Not financial advice.